MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Homozygous single base deletion in TUSC3 causes intellectual disability with developmental delay in an Omani family.
|
27148795 |
2016 |
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A novel nonsense mutation in TUSC3 is responsible for non-syndromic autosomal recessive mental retardation in a consanguineous Iranian family.
|
21739581 |
2011 |
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
Liver Cirrhosis, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systems level analysis and identification of pathways and networks associated with liver fibrosis.
|
25380136 |
2014 |
Intellectual Disability
|
0.190 |
Biomarker
|
group |
BEFREE |
A Homozygous 1.16 Megabases Microdeletion at 8p22 Including The Whole TUSC3 in A Three Years Old Girl with Intellectual Disability and Speech Delay.
|
31606977 |
2020 |
Intellectual Disability
|
0.190 |
GeneticVariation
|
group |
BEFREE |
For several years, the cause of autosomal recessive mental retardation has been attributed to the deletion or mutation of a gene named tumor suppressor candidate 3 (TUSC3).
|
29556302 |
2018 |
Intellectual Disability
|
0.190 |
GeneticVariation
|
group |
BEFREE |
TUSC3 mutations have been previously identified as causing either syndromic or non-syndromic ID in patients from France, Italy, Iran and Pakistan.
|
27148795 |
2016 |
Intellectual Disability
|
0.190 |
GeneticVariation
|
group |
BEFREE |
This study demonstrated an association between genetic polymorphisms of the TUSC3 gene and MR in the Qinba mountain area, the sixth exon of which might contribute to the risk of MR.
|
25966277 |
2015 |
Intellectual Disability
|
0.190 |
Biomarker
|
group |
BEFREE |
Although the pathogenic mechanism has not been clarified yet, our report argues for a more prominent role of TUSC3 in the etiology of intellectual disability and that deletions encompassing this gene could be more common than expected.
|
23825019 |
2013 |
Intellectual Disability
|
0.190 |
GeneticVariation
|
group |
BEFREE |
A novel deletion mutation in the TUSC3 gene in a consanguineous Pakistani family with autosomal recessive nonsyndromic intellectual disability.
|
21513506 |
2011 |
Intellectual Disability
|
0.190 |
GeneticVariation
|
group |
BEFREE |
A novel nonsense mutation in TUSC3 is responsible for non-syndromic autosomal recessive mental retardation in a consanguineous Iranian family.
|
21739581 |
2011 |
Intellectual Disability
|
0.190 |
GeneticVariation
|
group |
LHGDN |
Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation.
|
18455129 |
2008 |
Intellectual Disability
|
0.190 |
GeneticVariation
|
group |
BEFREE |
A defect in the TUSC3 gene is associated with autosomal recessive mental retardation.
|
18452889 |
2008 |
Intellectual Disability
|
0.190 |
Biomarker
|
group |
HPO |
|
|
|
Global developmental delay
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Homozygous single base deletion in TUSC3 causes intellectual disability with developmental delay in an Omani family.
|
27148795 |
2016 |
Global developmental delay
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Here, we show that Wnt/c-Myc signaling upregulates UHRF1, which in turn downregulates TUSC3, a candidate tumor suppressor gene that is frequently deleted or downregulated in several cancers.
|
31582837 |
2020 |
Body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry.
|
30239722 |
2019 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Overall, our observations suggest that TUSC3 accelerates cancer growth and induces the epithelial-mesenchymal transition in non-small-cell lung cancer cells; we also identified claudin-1 as a target of TUSC3.
|
30098333 |
2018 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The tumor suppressor candidate 3 (<i>TUSC3</i>) has been considered to be closely associated with the occurrence, development and invasion of various malignant tumors.
|
29503566 |
2018 |
Malignant Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
This revealed that lower levels of TUSC3 in gliomas may be associated with a poorly-differentiated (high grade) tumor and thus a higher malignancy.
|
29556302 |
2018 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
These findings provide mechanistic insight of unrecognized roles of TUSC3 in cancer progression and the oncogenic role of HRD1-dependent ERAD in cancer metastasis.
|
30504895 |
2018 |